Literature DB >> 11884471

Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen.

Franck J D Mennechet1, Lloyd H Kasper, Nicolas Rachinel, Wen Li, Alain Vandewalle, Dominique Buzoni-Gatel.   

Abstract

Acute and lethal ileitis can be elicited in certain strains of inbred mice after oral infection with the intracellular protozoan parasite Toxoplasma gondii. The development of this inflammatory process is dependent upon the induction of a robust Th1 response, including overproduction of IFN-gamma, TNF-alpha, and NO, as has been reported in other experimental models of human inflammatory bowel disease. In this study we have investigated the role of CD4(+) T cells from the lamina propria (LP) in the early inflammatory events after T. gondii infection using isolated and primary cultured intestinal cells from infected mice and immortalized mouse mIC(cl2) intestinal epithelial cells. Primed LP CD4(+) T cells isolated from parasite-infected mice produce substantial quantities of both IFN-gamma and TNF-alpha. IFN-gamma- and TNF-alpha-producing LP CD4(+) T cells synergize with infected mIC(cl2) and enhance the production of several inflammatory chemokines including macrophage-inflammatory protein-2, monocyte chemoattractant protein-1, monocyte chemoattractant protein-3, macrophage-inflammatory protein-1alphabeta, and IFN-gamma-inducible protein-10. Furthermore, primed LP CD4(+) T cells cocultured with infected mIC(cl2) inhibited replication of the parasite in the intestinal epithelial cells. Thus, LP CD4(+) T cells can interact with parasite-infected intestinal epithelial cells and alter the expression of several proinflammatory products that have been associated with the development of intestinal inflammation. The interaction between these two components of the gut mucosal compartment (CD4(+) T cells and enterocytes) may play a role in the immunopathogenesis of this pathogen-driven experimental inflammatory bowel disease model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884471     DOI: 10.4049/jimmunol.168.6.2988

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

Review 2.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

Review 3.  Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.

Authors:  S B Cohen; E Y Denkers
Journal:  Mucosal Immunol       Date:  2014-04-09       Impact factor: 7.313

4.  Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells.

Authors:  Torsten Sterzenbach; Sae Kyung Lee; Birgit Brenneke; Franz von Goetz; David B Schauer; James G Fox; Sebastian Suerbaum; Christine Josenhans
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections.

Authors:  Kathryn E McGovern; Emma H Wilson
Journal:  Curr Immunol Rev       Date:  2013

Review 6.  Interleukin 23 in Crohn's disease.

Authors:  Ahmet Eken; Akhilesh K Singh; Mohamed Oukka
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

7.  Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Authors:  Melba Muñoz; Markus M Heimesaat; Kerstin Danker; Daniela Struck; Uwe Lohmann; Rita Plickert; Stefan Bereswill; André Fischer; Ildikò Rita Dunay; Kerstin Wolk; Christoph Loddenkemper; Hans-Willi Krell; Claude Libert; Leif R Lund; Oliver Frey; Christoph Hölscher; Yoichiro Iwakura; Nico Ghilardi; Wenjun Ouyang; Thomas Kamradt; Robert Sabat; Oliver Liesenfeld
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

8.  CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.

Authors:  Luciana Benevides; Cristiane Maria Milanezi; Lucy Megumi Yamauchi; Cláudia Farias Benjamim; João Santana Silva; Neide Maria Silva
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

9.  Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection.

Authors:  Guillaume Oldenhove; Nicolas Bouladoux; Elizabeth A Wohlfert; Jason A Hall; David Chou; Liliane Dos Santos; Shaun O'Brien; Rebecca Blank; Erika Lamb; Sundar Natarajan; Robin Kastenmayer; Christopher Hunter; Michael E Grigg; Yasmine Belkaid
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

10.  Role of glucocorticoids and Toxoplasma gondii infection on murine intestinal epithelial cells.

Authors:  Stacy L Johnson; Radha Gopal; Amber Enriquez; Fernando P Monroy
Journal:  Parasitol Int       Date:  2014-05-27       Impact factor: 2.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.